CAS RN: 1415566-28-7
2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251231
25mg / 100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1415566-28-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1415566-28-7 / N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
Standard CAS: 1415566-28-7
Multi CAS: No
Basic Information
copy
CAS
1415566-28-7 copy
Multi CAS
No copy
Molecular Formula
C19H19N3O5S copy
Molecular Weight
401.400000 copy
Exact Mass
401.104542 copy
SMILES
C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=CS4 copy
InChI
InChI=1S/C19H19N3O5S/c23-17-12-26-8-7-21(17)13-3-5-14(6-4-13)22-11-15(27-19(22)25)10-20-18(24)16-2-1-9-28-16/h1-6,9,15H,7-8,10-12H2,(H,20,24)/t15-/m0/s1 copy
InChIKey
SJVCANNMDYDYLN-HNNXBMFYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.32 copy
Rotatable bonds
5 copy
H-bond acceptors
6 copy
H-bond donors
1 copy
Molar refractivity
103.88 copy
TPSA
88.18 copy
LogP / Solubility
WLOGP
1.87 copy
MLOGP
1.67 copy
XLogP3
1.5 copy
Consensus LogP
1.68 copy
Log S (ESOL)
-3.47 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.2 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.42 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.84 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy
Safety & Transport
copy
Pictogram(s)
Irritant copy
Signal
Warning copy
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] copy
Precautionary Statement Codes
P264, P270, P301+P317, P330, and P501 copy